Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas Braxton King currently holds 455,000 shares of Alexza Pharmaceuticals Inc. (ALXA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Braxton King has been a net seller of ALXA stock. They have purchased $509.0K and sold $1.1M worth of shares.
Thomas Braxton King's most recent insider trade was on Sep 4, 2025, when they sold 455,000 shares at $0.00 per share.
Thomas Braxton King serves as Executive at Alexza Pharmaceuticals Inc. (ALXA). They have executed 72 insider transactions totaling $1.6M over their tenure at the company.
Thomas Braxton King holds the position of Executive at Alexza Pharmaceuticals Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Thomas Braxton King has shown a selling trading pattern, with $509.0K in total purchases and $1.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Thomas Braxton King was on Mar 29, 2013, when they purchased $773.5K worth of ALXA shares. This transaction involved 175,000 shares at $4.42 per share.
Thomas Braxton King currently owns 455,000 shares of Alexza Pharmaceuticals Inc. (ALXA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas Braxton King's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas Braxton King has 72 Form 4 filings on record as an insider at Alexza Pharmaceuticals Inc..
Set alerts for Thomas Braxton King and 40,000+ other insiders.